Generation and modelling of megavoltage photon beams for contrast-enhanced radiation therapy

Contrast-enhanced radiation therapy (CERT) is a treatment approach involving the irradiation of tumours containing high atomic number (Z) contrast media, using low-quality x-ray beams. This work describes the experimental generation of x-ray beams using a linear accelerator with low-Z target materials (beryllium and aluminium), in order to produce photon energy spectra appropriate for CERT. Measurements were made to compare the experimental beams to conventional linear accelerator photon beams in terms of per cent depth dose. Monte Carlo simulation was used to model the generation of each beam, and models were validated against experimental measurement. Validated models were used to demonstrate changes in photon spectra as well as to quantify the variation of tumour dose enhancement with iodinated contrast medium concentration in a simulated tumour volume. Finally, the ratio of the linear attenuation coefficient for iodinated contrast medium relative to water was determined experimentally as a function of iodine concentration. Beams created with low-Z targets show significant changes in energy spectra compared to conventional beams. For the 4 MeV/Be beam, for example, 33% of photons have energies below 60 keV. Measurements and calculation show that both the linear attenuation coefficient ratio and dose enhancement factor (DEF) increase most rapidly at concentrations below 46 mg I ml(-1). There is a significant dependence of DEF on electron energy and a lesser dependence on target material. The 4 MeV/Be beam is the most promising in terms of magnitude of DEF - for example, DEF values of 1.16 and 1.29 are obtained for concentrations of 20 mg I ml(-1) and 50 mg I ml(-1), respectively. DEF will increase or decrease, respectively, for shallower or deeper tumours at a rate of approximately 1.1% cm(-1). In summary, we show that significant dose enhancement is possible by altering the linear accelerator target and filtration, but the magnitude is highly dependent on contrast medium concentration.

[1]  T. Solberg,et al.  Calculation of radiation dose enhancement factors for dose enhancement therapy of brain tumours. , 1992, Physics in medicine and biology.

[2]  T D Solberg,et al.  Dose distributions using kilovoltage x-rays and dose enhancement from iodine contrast agents. , 1999, Physics in medicine and biology.

[3]  B. Bjärngard,et al.  Attenuation in high-energy x-ray beams. , 1994, Medical physics.

[4]  I J Das,et al.  Gold microspheres: a selective technique for producing biologically effective dose enhancement. , 2000, International journal of radiation biology.

[5]  Frank Verhaegen,et al.  Dosimetric and microdosimetric study of contrast-enhanced radiotherapy with kilovolt x-rays , 2005, Physics in medicine and biology.

[6]  A F Bielajew,et al.  A thin target approach for portal imaging in medical accelerators. , 1998, Physics in medicine and biology.

[7]  J. Robar,et al.  Tumour dose enhancement using modified megavoltage photon beams and contrast media. , 2002, Physics in medicine and biology.

[8]  D. Rogers,et al.  EGS4 code system , 1985 .

[9]  U Titt,et al.  A flattening filter free photon treatment concept evaluation with Monte Carlo. , 2006, Medical physics.

[10]  R. H. Pratt,et al.  Bremsstrahlung energy spectra from electrons of kinetic energy 1 keV ≤ T1 ≤ 2000 keV incident on neutral atoms 2 ≤ Z ≤ 92 , 1977 .

[11]  H. E. Johns,et al.  Physics of Radiology , 1983 .

[12]  T Solberg,et al.  First radiotherapy of human metastatic brain tumors delivered by a computerized tomography scanner (CTRx). , 1999, International journal of radiation oncology, biology, physics.

[13]  D M Galbraith Low-energy imaging with high-energy bremsstrahlung beams. , 1989, Medical physics.

[14]  C. Ma,et al.  BEAM: a Monte Carlo code to simulate radiotherapy treatment units. , 1995, Medical physics.

[15]  R. H. Pratt,et al.  Electron bremsstrahlung energy spectra above 2 MeV , 1979 .

[16]  Keisuke S. Iwamoto,et al.  Iodinated Contrast Agents for Brain Tumor Localization and Radiation Dose Enhancement , 1991, Investigative radiology.

[17]  J. Motz Bremsstrahlung Differential Cross-Section Measurements for 0.5- and 1.0-Mev Electrons , 1955 .

[18]  J. Hainfeld,et al.  The use of gold nanoparticles to enhance radiotherapy in mice. , 2004, Physics in medicine and biology.

[19]  Marie-Claude Biston,et al.  Enhanced delivery of iodine for synchrotron stereotactic radiotherapy by means of intracarotid injection and blood-brain barrier disruption: quantitative iodine biodistribution studies and associated dosimetry. , 2005, International journal of radiation oncology, biology, physics.

[20]  R. Higashida,et al.  Radiation dose enhancement therapy with iodine in rabbit VX-2 brain tumors. , 1987, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  Sang Hyun Cho,et al.  Estimation of tumour dose enhancement due to gold nanoparticles during typical radiation treatments: a preliminary Monte Carlo study , 2005, Physics in medicine and biology.

[22]  P F O'Brien,et al.  Megavoltage imaging with low Z targets: implementation and characterization of an investigational system. , 1998, Medical physics.

[23]  M Gambaccini,et al.  Dual-energy tissue cancellation in mammography with quasi-monochromatic x-rays. , 2002, Physics in medicine and biology.

[24]  F Verhaegen,et al.  Optimization of accelerator target and detector for portal imaging using Monte Carlo simulation and experiment. , 2002, Physics in medicine and biology.

[25]  E. El-Khatib,et al.  Conversion of ionization measurements to radiation absorbed dose in non-water density material. , 1992, Physics in medicine and biology.

[26]  P F O'Brien,et al.  Radiosurgery with unflattened 6-MV photon beams. , 1991, Medical physics.